Infective causes of discharge Flashcards

1
Q

What is thrush?

A

This is a yeast infection of the lower female reproductive tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathogenesis of thrush?

A

85-90% of cases are due to candida albicans. Other organisms include Candida glabrata, Candida tropicalis, Candida krusei and Candida parapsilosis.

Candida is a normal commensal organism in the vagina.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk factors for thrush?

A
Pregnancy 
DM 
Antibiotics use 
Foreign bodies 
Chemotherapy 
Contraceptives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms and signs of thrush

A
Pruritus vulvae 
Vulval soreness 
White 'cheesy' discharge 
Dyspareunia 
Dysuria (external) 
Vulval erythema- possibly with fissuring 
Vulval oedema 
Satellite lesions 
Excoriation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differentials of thrush

A
BV 
Trichomonas vaginalis 
STIs 
Atrophic vaginitis 
Helminthic infection 
Lichen sclerosus 
Contact dermatitis 
Eczema 
Psoriasis 
UTIs 
Rectovesical fistula
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Investigations for thrush

A

Routine vaginal swabs are not required, in suspected bacterial/resistant or complicated infection.

Take swabs from the anterior fornix or lateral vaginal wall and send for microscopy, culture and sensitivity.

Take midstream specimen of urine (MSU) if symptoms could be due to urinary tract infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Management of thrush

A

Use a soap substitute to clean the vulval area, wear loose-fitting underwear, prescribe either an intravaginal antifungal such as clotrimazole or miconazole.

Severe infections are treated with two doses of oral fluconazole (150mg).

Intravaginal clotrimazole or miconazole should be used in pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Complications of thrush

A

Depression

Psychosexual problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the definition of BV?

A

BV is caused by an overgrowth of predominantly anaerobic organisms in the vagina. The most common organisms include Gardnerella vaginalis, Prevotella spp.

BV is the most common cause of abnormal vaginal discharge in women of reproductive age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for BV

A
Sexual activity
New sexual partner
Other STIs
Ethnicity
Presence of a IUCD
Vaginal douching
Bubble baths
Receptive oral sex
Smoking.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Protective factors against BV

A

Condom use
COC
Circumcised partner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Presentation of BV

A

Offensive, fishy-smelling vaginal discharge without soreness or irritation.

Half of all women infected are asymptomatic.

There is usually a thin layer of white discharge covering the vaginal wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differential diagnosis of BV

A

Other vaginal infection: candida, trichomoniasis, chlamydia, gonorrhoea, herpes simplex.

Other benign causes of vaginal discharge- physiological discharge, chemical irritants, foreign body, pregnancy, cervical ectropion.

Tumours of the vulva, vagina, cervix or endometrium

Postmenopausal vaginal discharge due to atrophic vaginitis

Vaginal discharge after gynae surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Investigations for BV

A

Amsel’s criteria require at least three of the following for diagnosis:

i. Homogeneous discharge as above.
ii. Microscopy showing vaginal epithelial cells coated with a large number of bacilli (‘clue cells’).
iii. Vaginal pH >4.5.
iv. Fishy odour on adding 10% potassium hydroxide to vaginal fluid.

Clinical diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of BV

A

a. Advise avoidance of vaginal douching, advise against the use of shower gel, asymptomatic women usually do not need treatment unless they are pregnant.

b. Treatment options are:
Oral metronidazole 400-500 mg bd for 5-7 days. Treatment of choice. This may be used in pregnant women.
Oral metronidazole 2 g stat. Avoid in pregnant women.
Metronidazole vaginal gel 0.75% once daily for five days.
Clindamycin vaginal gel 2% once daily for seven days.
Oral tinidazole 2 g stat.
Oral clindamycin 300 mg bd for seven days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications of BV

A

BV can increase the risk of acquiring and transmitting HIV and other STIs.

In pregnancy, BV is associated with various complications:

i. Late miscarriage
ii. Preterm delivery
iii. Premature rupture of membranes.
iv. Low birth weight
v. Postpartum endometritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is chlamydia?

A

Chlamydiae are small, obligate intracellular Gram-negative bacteria that infect human columnar and transitional epithelium.

Chlamydia trachomatis is responsible for:

i. Ocular infection (trachoma).
ii. Genitourinary infections.
iii. Proctitis.
iv. Sexually acquired reactive arthritis.
v. Lymphogranuloma venereum (a rare, sexually transmitted tropical infection causing genital ulcers and inguinal lymphadenopathy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Prevalence of chlamydia

A

It is the most commonly diagnosed sexually transmitted infection (STI) in the UK and the most common preventable cause of infertility worldwide.

It is asymptomatic in approximately 50% of men and at least 70% of women.

Sequelae can, however, include pelvic inflammatory disease (PID), ectopic pregnancy, tubal infertility in women and proctitis, epididymitis and epididymo-orchitis in men.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk factors for chlamydia

A
Age <25 years.
Sexual partner positive for chlamydia (two thirds of partners of people testing positive for chlamydia will test positive).
Two or more sexual partners in the preceding year.
A recent change in sexual partner.
Lack of consistent use of condoms.
Non-barrier contraception.
Infection with another STI.
Poor socio-economic status.
Genetic predisposition.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Presentation of chlamydia

A

Most cases are symptomatic.

Women present with vaginal discharge, dysuria, vague lower abdominal pain, fever, intermenstrual or postcoital bleeding, deep dyspareunia.

Men present with classical urethritis with dysuria and urethal discharge or epididymo-orchitis presenting as unilateral testicular pain and swelling.

In both sexes, young adults present with a reactive arthritis. Proctitis and pharyngeal infection.

-In women, signs can include:
A friable, inflamed cervix with contact bleeding.
Mucopurulent endocervical discharge
Abdominal tenderness
Pelvic adnexal tenderness on bimanual palpation
Cervical excitation

21
Q

Differential diagnosis of chlamydia

A

a. Gonorrhoea
b. Trichomonas vaginalis infection
c. UTI
d. BV
e. Endometriosis
f. Urethral/vaginal foreign body

22
Q

Investigations for chlamydia

A

Vulvovaginal swab for NAATs.

23
Q

Management for chlamydia

A

Antibiotic treatment of the index case- doxycycline 100mg (CI in pregnancy) or a single dose of 1g of azithromycin.
Pregnancy- erythromycin, amoxicillin or azithromycin
Screening for other STIs
Partner notification

24
Q

General advice for chlamydia

A

Chlamydia is primarily sexually transmitted.

Infection is very often asymptomatic and may have persisted for many months or even for years.

No diagnostic test is 100% sensitive.

Potential complications of not treating chlamydia.

The importance of investigating and treating sexual partners.

Agree on the method of partner notification.

The importance of complying with treatment.

Antibiotic side-effects and interactions.

Avoidance of sexual intercourse (genital, oral and anal sex) even with a condom for a week after single-dose therapy or until finishing a longer regimen.

The patient should not resume sex with their partner(s) until they too have completed treatment (or for a week following stat dose of azithromycin) or received negative test results; otherwise there is a high risk of re-infection.

It is important to test for other STIs, including human immunodeficiency virus (HIV) and hepatitis B.

Advice on safer sexual practices, contraception and condom use.

25
Q

Complications of chlamydia

A
PID 
Infertility 
Ectopic pregnancy 
Perihepatitis as part of Fitz-Hugh and Curtis syndrome 
Reactive arthritis
26
Q

What is the definition of gonorrhoea?

A

Neisseria gonorrhoeae is a Gram-negative diplococcus infecting mucous membranes of the urethra, endocervix, rectum, pharynx and conjunctiva.

Transmission occurs by the direct inoculation of infected secretions from one mucous membrane to another, usually sexually and, less commonly, perinatally.

The incubation period is usually taken as being between 2 and 5 days but may be up to 10 days.

27
Q

Risk factors for gonorrhoea

A
Young age
Hx of previous STI 
Co-existent STIs
New or multiple sexual partners 
Recent sexual activity abroad
Certain sexual activities eg. Anal intercourse, frequent insertive oral sex
Inconsistent condom use 
Hx of drug use or commercial sex work
28
Q

Presentation of gonorrhoea

A

Gonorrhoea is believed to be symptomatic in most men (90-95%) and asymptomatic in half of women.

Symptoms: Men present with urethral infection (discharge and/or dysuria), rectal infection or pharyngeal infection.

Women present with endocervical infection (discharge, lower abdominal pain), urethral infection, pharyngeal infection.

Signs in men include purulent urethral discharge and epididymal tenderness.

Signs in women include endocervical discharge, pelvic tenderness.

29
Q

Differentials of gonorrhoea

A
Chlamydia 
Endometriosis 
Appendicitis 
Pharyngitis 
Arthritis
30
Q

Investigations of gonorrhoea

A

Endocervical swab for NAATs

31
Q

Management for gonorrhoea

A

Allow time to provide a detailed explanation of the condition and its long-term implications for the patient and their partner’s/partners’ health, reinforced with written information.

Advise on safer sexual practices for the future.

Advise patients to avoid unprotected sexual intercourse until both they and their partner(s) have completed treatment.

Advise routine screening for other STIs in all patients with or at risk of gonorrhoea. Co-infection with other STIs, particularly chlamydia, is common.

Partner notification should preferably be performed by a trained health adviser.

Drug treatment- ceftriaxone 500mg plus azithromycin (1st line)

Cefixime and cefotaxime can be used.

32
Q

Complications of gonorrhoea

A
Gonococcal urethritis 
Prostatitis 
PID 
Bartholin’s abscess 
Peri-hepatitis (Fitz-Hugh Curtis)
Premature labour and miscarriage 
Corneal scarring and blindness from neonatal ophthalmic infection
33
Q

What is trichomonas vaginalis?

A

Trichomonas vaginalis is a very common sexually transmitted infection (STI) that can cause vaginitis, cervicitis and urethritis.

34
Q

Causes of trichomonas vaginalis

A

T. vaginalis is a flagellated protozoan.
In women the organism is found in the vagina, urethra and paraurethral glands.
Urethral infection is present in 90% of infected women.
In men infection is usually of the urethra.
In adults transmission is almost exclusively through sexual intercourse.

35
Q

Presentation of trichomonas vaginalis in women

A

The symptoms of T. vaginalis can be confused with bacterial vaginosis (BV).

Around 70% of women have a vaginal discharge.

Although this is usually a frothy yellowish discharge, it can vary from being thin and scanty to profuse and thick.

Other common symptoms include vulval itching, dysuria or offensive odour.

Lower abdominal discomfort can occur in some women.

There may be signs of local inflammation with vulvitis and vaginitis.

Cervicitis may be present which is called a strawberry cervix.

36
Q

Presentation of trichomonas vaginalis in men

A

Men are usually asymptomatic.

T. vaginalis is increasingly being recognised as a cause of non-gonococcal urethritis.

The most common symptoms are dysuria and presence of a urethral discharge.

The vast majority of men will have no abnormal signs on examination.

37
Q

Differential diagnosis of T. vaginalis

A

Candidiasis, BV, chlamydia, gonorrhoea, herpes simplex.

Postmenopausal vaginal discharge due to atrophic vaginitis.

Vaginal discharge after gynae surgery.

38
Q

Investigations of T. vaginalis

A

If T. vaginalis is suspected, a high vaginal swab can be taken from the posterior fornix but sensitivity may be low because motility reduces with transit time.

Women with suspected T. vaginalis should also have contact tracing undertaken.

Women with T. vaginalis need testing for other STIs.

Urethral culture or culture of first-void urine will diagnose 60-80% of cases in men.

Test of cure is only recommended if symptoms persist or recur.

39
Q

Management of T. vaginalis

A

Both partners should ideally be treated at the same time.

Sexual intercourse should be avoided for at least one week following receiving treatment.

All patients should receive clear and accurate written information about this condition.

Although TV is easily treated with metronidazole in most cases, resistant strains are on the increase.

Systemic treatments are far more effective than topical treatments and include:

  • Oral metronidazole 2 g as a single dose.
  • Oral metronidazole 400 mg to 500 mg bd for five to seven days.
  • Oral tinidazole 2 g single dose can be given as an alternative if metronidazole is not effective.
  • Treatment of partners is recommended, regardless of their results.
40
Q

Complications of T. vaginalis

A

Preterm delivery and low birth weight.

Postpartum sepsis

Enhance HIV transmission

Prostatitis

41
Q

What is herpes simplex?

A

Genital herpes simplex is caused by infection with the herpes simplex virus (HSV).

HSV is sub-divided into HSV type 1 (HSV-1) and HSV type 2 (HSV-2).

Type 1 is the usual cause of infections of the oral region and causes cold sores (herpes labialis). In the UK it is now also the most common cause of genital herpes.

Type 2 is associated with anogenital infection (penis, anus, vagina). It was the most common cause of genital infection but HSV-1 has overtaken it. HSV-2 is the most likely to cause recurrent anogenital infection.

However, both can infect the mouth and/or genitals, due to oral sex or autoinoculation.

42
Q

Transmission of herpes simplex

A

-Genital herpes is acquired from contact with:
Infectious secretions on oral, genital or anal mucosal surfaces.
Contact with lesions from other anatomical sites - eg, eyes, skin or herpetic whitlow.

-Therefore, the infection is transmitted through vaginal, anal and oral sex, close genital contact and contact with other sites such as the eyes and fingers.

43
Q

Risk factors for herpes simplex

A

Multiple sexual partners.

Previous history of STIs.

Early age of first sexual intercourse.

Unprotected sexual encounters.

Men who have sex with men (and female partners of men who have sex with men).

Female gender.

Human immunodeficiency virus (HIV) infection.

44
Q

Presentation of herpes simplex virus

A

In many cases there are no symptoms and the infected person does not know they have the disease and does not present to the medical profession.

Where the condition is symptomatic, it usually presents as multiple painful ulcers.

45
Q

What are the symptoms of Herpes simplex virus?

A

Febrile flu-like prodrome (5-7 days). Myalgia and fever are the main systemic symptoms.

Tingling neuropathic pain in the genital area/buttocks/legs.

Extensive painful crops of blisters/ulcers in the genital area (including the vagina and cervix in women and the urethra in men).

Lesions are usually bilateral in primary disease (usually unilateral in recurrent cases).

Tender lymph nodes (inguinal). Usually bilateral in primary disease.

Local oedema

Dysuria.

Vaginal or urethral discharge.

46
Q

Investigations for herpes simplex virus.

A

Viral culture

DNA detection using PCR of a swab from the base of an ulcer.

47
Q

Differential diagnosis of herpes simplex virus

A
Vulvo-vaginal candidiasis 
Gonorrhoea 
Non-gonococcal urethritis 
Syphilis 
BV
Scabies 
Psoriasis 
Reactive arthritis 
Herpes zoster
48
Q

Management of HSV

A

Advice includes:
Saline bathing (one teaspoon of salt in one pint of warm water).
Oral painkillers.
Topical lidocaine 5% gel or ointment is suitable analgesia.
Vaseline® or topical lidocaine may be applied to prevent pain during micturition.
Micturition whilst sitting in a bath can help prevent urinary retention.
Increase fluid intake to dilute urine to reduce pain during micturition.

-The British Association for Sexual Health and HIV (BASHH) guidelines advise first-line treatment should be five days of:
Aciclovir 400 mg three times daily; OR
Valaciclovir, 500 mg twice daily for five days.
-BASHH alternative regimens (also for five days) are:
Aciclovir 200 mg five times daily; OR
Famciclovir 250 mg three times daily.

49
Q

Complications of HSV

A

Autonomic neuropathy, resulting in urinary retention.
Aseptic meningitis.
Spread to extra-genital areas.
Secondary infection with candida or streptococci.
Perinatal transmission if the women is pregnant.
Psychological and psychosexual problems.